iRadimed Corporation develops, manufactures, markets and distributes Magnetic Resonance Imaging compatible products, and provides non-magnetic intravenous infusion pump systems. The Company operates through development, manufacture and sale of MRI compatible products and IV infusion pump systems for use by hospitals and acute care facilities during MRI procedures segment. Its MRidium MRI compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor, non-ferrous part and other features in order to deliver anesthesia and other IV fluids during various MRI procedures. In addition, it offers optional upgrade systems.

Type
Public
HQ
Winter Springs, US
Founded
2004
Size (employees)
80 (est)
IRadimed was founded in 2004 and is headquartered in Winter Springs, US
Report incorrect company information

IRadimed Office Locations

IRadimed has an office in Winter Springs
Winter Springs, US (HQ)
1025 Willa Springs Dr
Show all (1)
Report incorrect company information

IRadimed Financials and Metrics

IRadimed Financials

IRadimed's revenue was reported to be $23.08 m in FY, 2017
USD

Revenue (Q1, 2018)

7.1 m

Gross profit (Q1, 2018)

5.4 m

Gross profit margin (Q1, 2018), %

76.2%

Net income (Q1, 2018)

841.2 k

EBIT (Q1, 2018)

1.1 m

Market capitalization (21-May-2018)

198.7 m

Closing share price (21-May-2018)

18.7

Cash (31-Mar-2018)

20.1 m
IRadimed's current market capitalization is $198.7 m.
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2017

Revenue

15.7 m31.6 m32.5 m23.1 m

Revenue growth, %

102%3%

Cost of goods sold

3.4 m5.8 m6.2 m5.6 m

Gross profit

12.2 m25.8 m26.3 m17.5 m
Quarterly
USDQ2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018

Revenue

7.6 m8.2 m9 m9.9 m7.7 m5.2 m5.5 m5.7 m7.1 m

Cost of goods sold

1.4 m1.6 m1.7 m1.7 m1.4 m1.4 m1.2 m1.3 m1.7 m

Gross profit

6.2 m6.6 m7.3 m8.1 m6.3 m3.8 m4.3 m4.4 m5.4 m

Gross profit Margin, %

81%81%81%82%82%73%78%77%76%
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2017

Cash

9.5 m19.4 m17.7 m18.2 m

Accounts Receivable

2 m3.9 m3.8 m3.8 m

Inventories

276.5 k318 k362.9 k4.2 m

Current Assets

22.2 m34 m34.2 m35.1 m
Quarterly
USDQ3, 2017Q1, 2018

Cash

20.1 m

Inventories

287.1 k4.3 m

Current Assets

36.2 m

PP&E

1.9 m
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2017

Net Income

2.1 m7.5 m7.2 m499.8 k

Depreciation and Amortization

149.1 k223.9 k248.3 k1.3 m

Inventories

(154.9 k)(32 k)4.9 k(334.1 k)

Accounts Payable

201.7 k376.3 k1.1 k(523.4 k)
Quarterly
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Net Income

1.8 m1.9 m2.3 m2.2 m1.6 m(233.3 k)192.4 k

Inventories

287.1 k

Accounts Payable

989.1 k640.2 k781.6 k1 m916.9 k1.2 m1.2 m991.9 k859.1 k736.9 k794.4 k
USDY, 2018

Financial Leverage

1.2 x
Show all financial metrics

IRadimed Operating Metrics

FY, 2016

Patents Issued

14
Show all operating metrics
Report incorrect company information